Signal transduction is the mechanism by which a cell receives, transmits, processes and converts a signal into a functional outcome. When signaling pathways become unregulated, disease results.
Signal transduction allows cells to receive, interpret and respond to signals – whether external signals originating from neighboring cells, environmental factors or internal signals. Their often tightly regulated cascades enable cellular communication, direct development and maintenance of tissues and organs, control basic cellular processes like cell growth and death, respond to attacks by foreign invaders and more.
While the particulars of each signal transduction pathway are unique, they often share certain component types. Most start with a signal, often a neurotransmitter, growth factor or hormone, activating a receptor that triggers a cascade of events. Some pathways utilize second messengers, small intracellular molecules, to transmit and amplify the signal. Calcium (Ca2+) is a common second messenger. In response to a signal, pumps and channels at the membrane transport Ca 2+ into the cell. As it accumulates, Ca 2+ facilitates binding by calcium-sensing proteins such as calmodulin (CaM), which results in regulation of downstream proteins, particularly those involved in muscle contraction (1). Other common second messengers include cAMP, cGMP, diacylglycerol (DAG) and inositol trisphosphate (IP3).
Less common second messengers include nitric oxide (NO), a free radical produced by eNOS signaling. A ubiquitously expressed, calcium-dependent isoform of nitric oxide synthase (NOS), eNOS catalyzes the conversion of L-Citruline to L-Arginine to produce NO, which has effects on blood pressure, blood vessel dilation and more (2).
Another common component for transmitting and amplifying the signal are kinases, including both tyrosine kinases and serine/threonine kinases. One example is the Tec kinases, a family of non-receptor protein tyrosine kinases (PTKs) expressed predominately in hematopoietic cells. Tec kinase signaling acts downstream of cytokine- and antigen-stimulated receptors, as well as GPCRs and integrins, exerting effects on a wide variety of processes including development of the hematopoietic system, immune response, cell adhesion and migration and more (3).
Kinases and their targets are often stabilized by adaptor and scaffolding proteins that act as signaling hubs. In the case of serine-threonine kinases, the 14-3-3 family of proteins often plays that role. As highly adaptable hubs, 14-3-3 mediated signaling plays a critical role in a wide range of cellular processes, acting as an inhibitor, activator, structural stabilizer or translocation aid depending on the situation (4).
Regardless of the mechanism of signal amplification, the ultimate target of signal transduction is often transcription factors and their regulated genes. While there are many different families of transcription factors, HIF1 and NF-κB provide two examples. HIF1 is a heterodimer composed of HIF1α and HIF1-β. While HIF1-β is constitutively expressed, HIF1α accumulates under hypoxic conditions. In response to low oxygen levels, HIF1α is regulated by multiple pathways including the PI3K/AKT, PKA and MAPK/ERK pathways, affecting its stability, inhibiting its degradation and promoting its accumulation, which drives expression of HIF1 target genes (5).
In inflamed tissue, hypoxia signaling and HIF1 activation can both promote and inhibit immune system activity, depending on the cell type and context (5). One of the targets is the NF-κB pathway. Nuclear factor kappa B (NF-κB) transcription factors are hetero or homodimers composed of five known subunits: RELA/p65, c-REL, RELB, p50 and p52. Inactive NF-κB resides in the cytoplasm, bound by IκB. In response to a wide variety of stress-inducing extracellular stimuli, IκB becomes phosphorylated and targeted for degradation, freeing NF-κB to translocate to the nucleus and bind to DNA, activating gene targets involved in inflammatory response.
Many distinct pathways driving cell fate and development have been described. A few examples include the following:
Netrin signaling provides an example of signaling pathway activities that extend beyond cell fate and early development. Netrin is one of several secreted guidance cues that provide directional information to migrating neurons, attracting some axons while repelling others (9). When netrin acts solely through the DCC (Deleted in Colorectal Cancer) family of receptors without UNC-5, it has an attractive effect, with activation of DCC triggering cAMP-dependent signaling that enhances calcium channel activity leading to an influx of Ca2+. But when UNC5 binds to DCC, the activated complex triggers cGMP signaling that decreases Ca2+ currents, leading to repulsion of growth cones.
Other pathways have highly specific effects on specific cell types, as demonstrated by the impact of PEDF signaling on neurons. Pigment epithelium derived factor (PEDF) signaling protects against glutamate excitotoxicity in cerebellar granule neurons, promoting their survival by activating the NF-κB signaling pathway discussed above. PEDF is also involved in retinal neuron survival (10).